Francesco Rossi

Dr. Francesco Rossi

Nanotechnology and Molecular Science, Ca' Foscari University of Venice, Venice, Veneto, Italy
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Nano Today
Verified
Journal Article
Closed access
SSS.K. Sharma
S.K. Sharma
NSNavadeep Shrivastava
Navadeep Shrivastava
FRFrancesco Rossi
Francesco Rossi
LTLe Duc Tung
Le Duc Tung
NTNguyen Thi Kim Thanh
Nguyen Thi Kim Thanh

19 August 2024 in Nanoscale
Verified
Journal Article
Open access
PDF file
FRFrancesco Rossi
Francesco Rossi
TTThithawat Trakoolwilaiwan
Thithawat Trakoolwilaiwan
VGValeria Gigli
Valeria Gigli
CTCristina Tortolini
Cristina Tortolini
ALAndrea Lenzi
Andrea Lenzi
RARiccarda Antiochia
Riccarda Antiochia
A critical comparison between different types of nanoparticle-based electrochemical biosensors for the detection of various hormones.

3 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
GSGianmarco Stati
Gianmarco Stati
FRFrancesco Rossi
Francesco Rossi
TTThithawat Trakoolwilaiwan
Thithawat Trakoolwilaiwan
LTLe Duc Tung
Le Duc Tung
SMStefanos Mourdikoudis
Stefanos Mourdikoudis
Roberta Di PietroRoberta Di Pietro
Roberta Di Pietro
Pterygium is a progressive disease of the human eye arising from sub-conjunctival tissue and extending onto the cornea. Due to its invasive growth, pterygium can reach the pupil compromising visual function. Currently available medical treatments have limited success in suppressing efficiently the disease. Previous studies have demonstrated that curcumin, polyphenol isolated from the rhizome of Curcuma longa, induces apoptosis of human pterygium fibroblasts in a dose- and time-dependent manner showing promising activity in the treatment of this ophthalmic disease. However, this molecule is not very soluble in water in either neutral or acidic pH and is only slightly more soluble in alkaline conditions, while its dissolving in organic solvents drastically reduces its potential use for biomedical applications. A nanoformulation of curcumin stabilized silver nanoparticles (Cur-AgNPs) seems an effective strategy to increase the bioavailability of curcumin without inducing toxic effects. In fact, silver nitrates have been used safely for the treatment of many ophthalmic conditions and diseases for a long time and the concentration of AgNPs in this formulation is quite low. The synthesis of this new compound was achieved through a modified Bettini’s method adapted to improve the quality of the product intended for human use. Indeed, the pH of the reaction was changed to 9, the temperature of the reaction was increased from 90 °C to 100 °C and after the synthesis the Cur-AgNPs were dispersed in Borax buffer using a dialysis step to improve the biocompatibility of the formulation. This new compound will be able to deliver both components (curcumin and silver) at the same time to the affected tissue, representing an alternative and a more sophisticated strategy for the treatment of human pterygium. Further in vitro and in vivo assays will be required to validate this formulation.

21 January 2014 in Drug Safety
Verified
Journal Article
Closed access
PDF file
ECEU-ADR consortium
EU-ADR consortium
CFCarmen Ferrajolo
Carmen Ferrajolo
PCPreciosa M. Coloma
Preciosa M. Coloma
KVKatia M. C. Verhamme
Katia M. C. Verhamme
MSMartijn J. Schuemie
Martijn J. Schuemie
MSMiriam C. J. M. Sturkenboom
Miriam C. J. M. Sturkenboom

6 March 2016 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
SSShailendra R Singh
Shailendra R Singh
NSNikol Sullo
Nikol Sullo
MMMaria Matteis
Maria Matteis
GSGiuseppe Spaziano
Giuseppe Spaziano
JMJohn McDonald
John McDonald
DLDavid G Lambert
David G Lambert
Background and Purpose: There is evidence supporting a role for the nociceptin/orphanin FQ (N/OFQ; NOP) receptor and its endogenous ligand N/OFQ in the modulation of neurogenic inflammation, airway tone and calibre. We hypothesized that NOP receptor activation has beneficial effects upon asthma immunopathology and airway hyperresponsiveness. Therefore, the expression and function of N/OFQ and the NOP receptor were examined in healthy and asthmatic human airway tissues. The concept was further addressed in an animal model of allergic asthma.Experimental Approach: NOP receptor expression was investigated by quantitative real‐time PCR. Sputum N/OFQ was determined by RIA. N/OFQ function was tested using several assays including proliferation, migration, collagen gel contraction and wound healing. The effects of N/OFQ administrationin vivowere studied in ovalbumin (OVA)‐sensitized and challenged mice.Key Results: NOP receptors were expressed on a wide range of human and mouse immune and airway cells. Eosinophils expressed N/OFQ‐precursor mRNA and their number correlated with N/OFQ concentration. N/OFQ was found in human sputum and increased in asthma. Additionally, in asthmatic human lungs N/OFQ immunoreactivity was elevated. NOP receptor activation inhibited migration of immunocytes and increased wound healing in airway structural cells. Furthermore, N/OFQ relaxed spasmogen‐stimulated gel contraction. Remarkably, these findings were mirrored in OVA‐mice where N/OFQ treatment before or during sensitization substantially reduced airway constriction and immunocyte trafficking to the lung, in particular eosinophils. N/OFQ also reduced inflammatory mediators and mucin production.Conclusions and Implications: We demonstrated a novel dual airway immunomodulator/bronchodilator role for N/OFQ and suggest targeting this system as an innovative treatment for asthma.

14 May 2019 in ACS Applied Bio Materials
Verified
Journal Article
Open access
FRFrancesco Rossi
Francesco Rossi
Thanh Nguyen T. K.Thanh Nguyen T. K.
Thanh Nguyen T. K.
XSXiaodi Su
Xiaodi Su
For the first time, anisotropic gold nanorods (AuNRs) were embedded with a photosensitizer dye (crystal violet) in polyurethane (PU) matrix to create the effective antimicrobial film, capable of killing gram negative bacteria on its surface when exposed to white light. The dye, when activated with white light, interact with the AuNRs, to generate reactive oxygen species (ROS) which kill bacteria. With a proper control of the aspect ratio (2.1-2.4) and coating of the AuNRs, the film can be tuned to reduce the bacteria population of one to four orders of magnitude (1-log to 4-log) under 11 klux of light, for an exposure to light between 1 to 3 h. Particularly it could reduce 104 cfu/cm2 to the level of 1 – 5 cfu/cm2 in 3 h of light exposure. This was a desired performance for use in hospital surfaces. In addition, the system showed antimicrobial effect only when exposed to light which eliminated the concern for a cumulative toxic effect on subjects exposed to the material for a long period of time and limits the time given to the bacteria to develop resistance against the system. Furthermore, this process of sterilization could be carried out by a commercially available white light lamp, which when in use did not interrupt the normal routine operation of the environment.